Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Men with low ...

Please provide your email address to receive an email when new articles are posted on . High hematocrit levels were observed among 8.4% of adults receiving gender-confirming testosterone therapy.

Testosterone substitution in male hypogonadism is a recognized tool to treat symptomatic patients. Various forms of this treatment exist including a long-acting intramuscular form using testosterone ...

Please provide your email address to receive an email when new articles are posted on . Testosterone therapy with intramuscular testosterone undecanoate did not result in any adverse cardiovascular or ...

Urologic evaluation before treatment is indicated when baseline prostate specific antigen (PSA) is ≥4 ng/mL (3 ng/mL for those at increased risk of prostate cancer, such as African-Americans and men ...

In the latest addition to the ongoing debate over the safety of testosterone treatment, researchers report no significant increased heart-attack risk in older men treated with an intramuscular form of ...

Doctor measuring an overweight man’s waist using a tape measure. Additional safety data on testosterone therapy are needed before it can be used to prevent type 2 diabetes. Testosterone treatment may ...

WOBURN, Mass., Dec. 12, 2024 /PRNewswire/ -- Azurity Pharmaceuticals announced today the availability of Azmiro™, the first and only FDA-approved prefilled testosterone cypionate injection. Azmiro is ...